News Releases


 

Feb 23, 2017

Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update

Feb 16, 2017

Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017

Feb 14, 2017

Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent

Jan 4, 2017

Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference

Nov 14, 2016

Insmed to Participate at November Investor Conferences

Nov 3, 2016

Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update

Oct 27, 2016

Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016

Oct 18, 2016

Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease

Oct 5, 2016

Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor

Sep 27, 2016

Insmed Appoints Roger Adsett as Chief Commercial Officer